Company profile: Exos
1.1 - Company Overview
Company description
- Provider of thermoformable external musculoskeletal stabilization systems, developing and commercializing adjustable, reformable technology that addresses various pathologies for upper and lower extremity and spinal areas.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Exos
Providence Medical Technology
HQ: United States
Website
- Description: Provider of medical devices and training focused on cervical spinal conditions, offering CORUS instruments for posterior cervical and lumbar fusion, the CAVUX Facet Fixation System and CAVUX Cervical Cage implants, the ALLY Bone Screw for supplemental fixation, ENTRUS structural allograft bone grafts, and training in surgical simulation, anatomical models, local bioskills courses, and national training courses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Providence Medical Technology company profile →
Archus Orthopedics
HQ: United States
Website
- Description: Provider of reconstructive spinal implants to treat degenerative lumbar spine diseases and facet joint disorders, including the Total Facet Arthroplasty System for patients with lumbar spinal stenosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Archus Orthopedics company profile →
GQ Bio Therapeutics
HQ: Germany
Website
- Description: Provider of gene therapy, drug development, and medicines for osteoarthritis and intervertebral disc degeneration, leveraging an HCAd vector platform to deliver large and multiple genes and single-injection therapies that establish long-term therapeutic protein production in affected musculoskeletal tissues.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GQ Bio Therapeutics company profile →
Horizon Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical development focused on prescription drugs for mild to moderate pain relief and arthritis. Product candidates include HZT-501, a proprietary fixed-dose combination formulation of NSAID and ibuprofen, and HZT-602, a combination oral drug product.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Horizon Therapeutics company profile →
Eventum Orthopaedics
HQ: United Kingdom
Website
- Description: Provider of a real-time measurement device for knee replacement surgery, delivering real-time measurements of the knee area during operations to help surgeons improve decision-making and surgical outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eventum Orthopaedics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Exos
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Exos
2.2 - Growth funds investing in similar companies to Exos
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Exos
4.2 - Public trading comparable groups for Exos
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →